SIM
IMNM icon

Sandia Investment Management’s Immunome IMNM Stock Holding History

Sandia Investment Management’s Portfolio IMNM Stock Details IMNM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$215K Buy
+10,000
New +$176K 0.54% 67

Other funds holding IMNM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
ES
Enavate Sciences Menlo Park, California $352M AUM 220.14% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return

Sandia Investment Management's IMNM Position: Q4 2025 in Review

Sandia Investment Management opened a new position in Immunome (IMNM) in Q4 2025: 10,000 shares worth $215K. The stake represents 0.54% of the portfolio and ranks #67 among its holdings.

182 funds tracked by Wall St. Rank hold IMNM as of Q4 2025.

  • Sandia Investment Management held 10,000 shares of Immunome worth $215K as of Q4 2025.
  • Immunome was a new Sandia Investment Management position in Q4 2025.
  • Immunome made up 0.54% of Sandia Investment Management's portfolio in Q4 2025, its #67 holding.
  • 182 funds tracked by Wall St. Rank held Immunome as of Q4 2025.

Based on Sandia Investment Management's 13F filing for Q4 2025, filed 17 Feb 2026.